Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The purpose of this study is to evaluate efficacy and of safety QL0911 in the treatment of thrombocytopenia in pediatric patients with previously treated chronic ITP.
Epistemonikos ID: 8093c25718b32d68f3f9e7da709b6a6acc1f319f
First added on: Mar 07, 2026